Baidu
map

Stroke:机械性血栓切除术后实质性血肿的预测因子

2019-07-23 xing.T MedSci原创

由此可见,机械性血栓切除术后PH发生率为11.6%,发病率和死亡率较高。该研究确定了PH发生的临床、影像学和手术预测因子,可以作为未来围手术期管理研究的重点,旨在减少其发生。

实质性血肿(PH)是急性缺血性卒中罕见但可怕的并发症,其潜在机制尚不清楚。近日,心血管疾病领域权威杂志Stroke上发表了一篇研究文章,研究人员的目的是探究机械性血栓切除术后PH的发生率和预测因素。 

研究人员筛选了来自前瞻性观察多中心登记处的数据,以确定接受机械血栓切除术的前循环大血管闭塞的急性缺血性卒中患者。临床、成像和手术特征用于分析,包括在24小时进行的脑成像检查。根据ECASS(欧洲协作急性卒中研究)标准评估PH发生率。研究人员进行单变量和多变量分析以确定PH的预测因子。

该研究共纳入1316名患者。1316例患者中有153例(11.6%)发生PH,并且有利结果发生率较低且死亡率增加。在多变量分析,年龄(每增加1岁的比值比[OR]为1.01; 95%CI为1.00-1.03; P=0.05)、目前吸烟(OR为2.02; 95%CI为1.32-3.09; P<0.01)、入院艾伯塔卒中项目早期CT评分(每减少1分的OR为1.70; 95%CI为1.18-2.44; P<0.01)、全身麻醉(OR为1.98; 95%CI为1.36-2.90; P<0.001)、血管造影侧支不良(OR​​为2.13; 95%CI为1.36-3.33; P<0.001)和新区域栓塞(OR为2.94; 95%CI为1.70-5.10; P <0.001)被确定为独立的PH预测因子。 

由此可见,机械性血栓切除术后PH发生率为11.6%,发病率和死亡率较高。该研究确定了PH发生的临床、影像学和手术预测因子,可以作为未来围手术期管理研究的重点,旨在减少其发生。 

原始出处:

William Boisseau.et al.Predictors of Parenchymal Hematoma After Mechanical Thrombectomy A Multicenter Study.stroke.2019.https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.024512

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877180, encodeId=49b818e7180ec, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Thu May 14 09:54:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310736, encodeId=18be1310e3675, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314275, encodeId=01fe13142e58a, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394950, encodeId=7f35139495009, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401029, encodeId=bb161401029fc, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404902, encodeId=1f801404902bd, content=<a href='/topic/show?id=40d4612555f' target=_blank style='color:#2F92EE;'>#机械性血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61255, encryptionId=40d4612555f, topicName=机械性血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2501320, createdName=zlawrance, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877180, encodeId=49b818e7180ec, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Thu May 14 09:54:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310736, encodeId=18be1310e3675, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314275, encodeId=01fe13142e58a, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394950, encodeId=7f35139495009, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401029, encodeId=bb161401029fc, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404902, encodeId=1f801404902bd, content=<a href='/topic/show?id=40d4612555f' target=_blank style='color:#2F92EE;'>#机械性血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61255, encryptionId=40d4612555f, topicName=机械性血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2501320, createdName=zlawrance, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877180, encodeId=49b818e7180ec, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Thu May 14 09:54:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310736, encodeId=18be1310e3675, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314275, encodeId=01fe13142e58a, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394950, encodeId=7f35139495009, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401029, encodeId=bb161401029fc, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404902, encodeId=1f801404902bd, content=<a href='/topic/show?id=40d4612555f' target=_blank style='color:#2F92EE;'>#机械性血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61255, encryptionId=40d4612555f, topicName=机械性血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2501320, createdName=zlawrance, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877180, encodeId=49b818e7180ec, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Thu May 14 09:54:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310736, encodeId=18be1310e3675, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314275, encodeId=01fe13142e58a, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394950, encodeId=7f35139495009, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401029, encodeId=bb161401029fc, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404902, encodeId=1f801404902bd, content=<a href='/topic/show?id=40d4612555f' target=_blank style='color:#2F92EE;'>#机械性血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61255, encryptionId=40d4612555f, topicName=机械性血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2501320, createdName=zlawrance, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1877180, encodeId=49b818e7180ec, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Thu May 14 09:54:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310736, encodeId=18be1310e3675, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314275, encodeId=01fe13142e58a, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394950, encodeId=7f35139495009, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401029, encodeId=bb161401029fc, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404902, encodeId=1f801404902bd, content=<a href='/topic/show?id=40d4612555f' target=_blank style='color:#2F92EE;'>#机械性血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61255, encryptionId=40d4612555f, topicName=机械性血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2501320, createdName=zlawrance, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1877180, encodeId=49b818e7180ec, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Thu May 14 09:54:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310736, encodeId=18be1310e3675, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314275, encodeId=01fe13142e58a, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394950, encodeId=7f35139495009, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401029, encodeId=bb161401029fc, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404902, encodeId=1f801404902bd, content=<a href='/topic/show?id=40d4612555f' target=_blank style='color:#2F92EE;'>#机械性血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61255, encryptionId=40d4612555f, topicName=机械性血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16bc2501320, createdName=zlawrance, createdTime=Wed Jul 24 23:54:00 CST 2019, time=2019-07-24, status=1, ipAttribution=)]

相关资讯

应基于CT灌注结果选择机械性血栓切除预后好

    于7月末召开的神经介入外科学会年会上公布的一项单中心研究显示,基于CT灌注结果选择进行机械性血栓切除术的卒中患者,即使在传统7~8 h治疗窗后治疗,仍能获得良好功能预后,并且安全性较好。    在这项研究中,南卡罗莱纳医科大学的Jordan Magarik及其同事对该校卒中中心2008~2011年收治的140例卒中患者的病历进行了

Circulation:转院会延迟脑卒中患者进行血栓切除术的时间,降低预后。

应用机械性血栓切除术(MT)的血管内治疗对有大血管阻塞的急性脑卒中患者大有裨益,但治疗效果具有高度的时间依赖性。Michael T.Froehler及其同事假设与直接进入心血管中心相比,医院间转移会延迟治疗,降低临床预后。

Stroke:机械性血栓切除术对治疗轻中度脑卒中患者益处!

近端大血管闭塞(LVO)约占轻微中风患者比例的30%。目前,关于机械性血栓切除术(MT)在前循环LVO轻微卒中亚组中的治疗有效性仍有争议。关于这一亚组患者的MT研究数据很少,而且关于他们的最佳管理尚未确定。基于此,近期,一项发表在杂志Stroke上的多中心队列研究旨在评估由于前循环中LVO的急性缺血性中风(AIS)患者使用MT的有效性,研究对象为呈现轻度至中度中风症状(National Insti

Stroke:机械性血栓切除术治疗的大血管闭塞患者HbA1c与临床结局的关系

这些结果表明,在采用MT治疗的大血管闭塞患者中,较高HbA1c水平是AIS后3个月不良预后的独立预测因子,特别是在血管再通的患者中,并且可能增加AIS后死亡和早期临床恶化的风险。

Baidu
map
Baidu
map
Baidu
map